Genome-Derived Classification Signature for Ampullary Adenocarcinoma to Improve Clinical Cancer Care.
Saptarshi ChakrabortyBrett L EckerKenneth P SeierVictoria G AvesonVinod P BalachandranJeffrey A DrebinMichael I D'AngelicaT Peter KinghamCarlie S SigelKevin C SoaresEfsevia VakianiAlice C WeiRohit ChandwaniMithat GönenRonglai ShenWilliam R JarnaginPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
The genomic classifier provides insight into the heterogeneity of ampullary adenocarcinoma and improves stratification, which is dictated by the proportion of colorectal and pancreatic genomic alterations. This approach is reproducible with available molecular testing and obviates subjective histologic interpretation.